Rare Tumors

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Rare Tumors is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,000 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2036-3605 · 2036-3613
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,000 USD
Articles in DOAJ
704
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2009-08-05
  • PUBMED · 2009-07-22
Indexing
DOAJ · PUBMED
APC
2,000 USD
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

704

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

708

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

32

i10-index

272

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-04-04
Added to DOAJ
2009-08-05
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
99%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101526926
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Cardiac tumors and thrombi
  • Vascular Tumors and Angiosarcomas
  • Vascular Tumors and Angiosarcomas
  • Bone Tumor Diagnosis and Treatments
  • Bone Tumor Diagnosis and Treatments
Show all subjects (50)
  • Tumors and Oncological Cases
  • Tumors and Oncological Cases
  • Soft tissue tumor case studies
  • Soft tissue tumor case studies
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Oral and Maxillofacial Pathology
  • Urologic and reproductive health conditions
  • Oral and Maxillofacial Pathology
  • Urologic and reproductive health conditions
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Ear and Head Tumors
  • Ear and Head Tumors
  • Neurofibromatosis and Schwannoma Cases
  • Neurofibromatosis and Schwannoma Cases
  • Urinary and Genital Oncology Studies
  • Urinary and Genital Oncology Studies
  • Histiocytic Disorders and Treatments
  • Viral-associated cancers and disorders
  • Gastrointestinal Tumor Research and Treatment
  • Viral-associated cancers and disorders
  • Histiocytic Disorders and Treatments
  • Gastrointestinal Tumor Research and Treatment
  • Testicular diseases and treatments
  • Meningioma and schwannoma management
  • Testicular diseases and treatments
  • Meningioma and schwannoma management
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Research Studies
  • Ovarian cancer diagnosis and treatment
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Pancreatic and Hepatic Oncology Research

Keywords (DOAJ)

  • rare cancers
  • haematological malignancies
  • rare tumours

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: